SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 138 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $638,000 | +90.4% | 35,570 | +25.4% | 0.00% | +33.3% |
| Q3 2017 | $335,000 | +20.9% | 28,371 | +7.6% | 0.00% | 0.0% |
| Q2 2017 | $277,000 | -9.2% | 26,360 | -5.0% | 0.00% | 0.0% |
| Q1 2017 | $305,000 | -33.8% | 27,738 | -18.5% | 0.00% | -40.0% |
| Q4 2016 | $461,000 | +20.1% | 34,044 | +9.1% | 0.01% | 0.0% |
| Q3 2016 | $384,000 | -5.2% | 31,211 | -15.5% | 0.01% | 0.0% |
| Q2 2016 | $405,000 | +1.2% | 36,954 | +1.0% | 0.01% | -16.7% |
| Q1 2016 | $400,000 | -42.3% | 36,585 | -8.7% | 0.01% | -25.0% |
| Q4 2015 | $693,000 | -5.5% | 40,063 | +8.6% | 0.01% | -20.0% |
| Q3 2015 | $733,000 | +13.8% | 36,879 | -6.0% | 0.01% | +11.1% |
| Q2 2015 | $644,000 | +4.7% | 39,219 | -0.8% | 0.01% | +28.6% |
| Q1 2015 | $615,000 | +29.7% | 39,539 | +19.2% | 0.01% | +16.7% |
| Q4 2014 | $474,000 | +144.3% | 33,179 | +11.1% | 0.01% | +100.0% |
| Q3 2014 | $194,000 | -20.8% | 29,869 | -15.9% | 0.00% | 0.0% |
| Q2 2014 | $245,000 | -26.2% | 35,511 | -23.5% | 0.00% | -25.0% |
| Q1 2014 | $332,000 | +79.5% | 46,393 | +136.3% | 0.00% | +33.3% |
| Q4 2013 | $185,000 | +25.9% | 19,637 | -16.7% | 0.00% | 0.0% |
| Q3 2013 | $147,000 | +48.5% | 23,569 | +56.5% | 0.00% | +50.0% |
| Q2 2013 | $99,000 | – | 15,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |